Preliminary experiments excluded the possibility that the CAV1-mediated activity of RES was due to direct CAV1-dependent activation of ERα and ERβ and proposed a novel mechanism responsible for RES-CAV1 mediated anti-cancer activity in HCC. Here, ESR1 is linked to hepatocellular carcinoma.